2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its ...

A global conference showcasing AI-led scientific research revealed both the growing role of AI in academia and its persistent ...

Once this policy is enacted, it will be illegal for Americans to retain any mental impression longer than that little haptic ...

Sarepta Therapeutics, Inc. faces revenue decline, trial setbacks, and FDA decisions. Click for SRPT risks, outlook, and if ...

Global stocks mostly fell Tuesday as investors weighed the recent tech rally on Wall Street against growing fears of an AI ...

Aurinia alleges that Tidmarsh’s statements were not only inaccurate but also motivated by a personal vendetta against Kevin ...

Discover why Alexandria Real Estate Equities is a top REIT pick for long-term gains and dividends after a price dip. Click ...

Brock did, in fact, find bacteria reproducing inside the hot springs — a discovery critical to the development of polymerase chain reaction, a DNA sequencing method that has advanced biotech ... of ...

The Indian Council of Agricultural Research (ICAR) on Thursday rejected allegations of scientific fraud in the testing of two genome-edited rice varieties, terming the claims "baseless" and motivated ...